FemmeHealth Alliance (FHA) launches to bridge Europe’s women’s health innovation gap
16.10.2025 10:05:00 CEST | news aktuell GmbH | Press Release
Zurich, Switzerland — October 16, 2025 — FemmeHealth Alliance, a Swiss non-profit association (Verein), today announced its launch to strengthen collaboration in women’s-health innovation across Europe. FHA will convene leaders across the capital, corporate, clinical, and policy ecosystem through virtual and in-person events, anchored by a new research and dialogue series and supported by a partner community.
“Europe has world-class science in women’s health, but solutions often remain stuck in silos,” said Maryann Umoren Selfe, Founder & President of FHA. “FHA exists to change that by creating a platform where capital, science, and policy share the same agenda.”
“FHA’s mission is to accelerate progress in women’s health by fostering collaboration across sectors and ensuring that scientific advances translate into accessible, real-world solutions,” added Emmanuelle Lecomte-Brisset, Legal Co-Founder of FHA.
The Alliance will open with The Business of Women’s Health 2025: Key Trends and Insights, a virtual briefing on October 23, 2025, 18:00–19:00 CEST. The event is open to partners and non-members. FHA membership provides access to webinars, a members-only library, and invitations to in-person convenings. FHA also welcomes partners and supporters to join its coalition dedicated to closing the gender-health equity gap.
Industry leaders are already welcoming the launch.
“FemmeHealth Alliance serves as a vital bridge between innovators and investors. By establishing a consistent forum for collaboration, it will accelerate the growth of credible women’s-health solutions across Switzerland and Europe,” said Daniel Delfosse, Vice Director, Swiss Medtech.
About FemmeHealth Alliance
FemmeHealth Alliance (FHA) is a Swiss non-profit association (Verein) dedicated to advancing women’s health innovation through education, convenings, and partnerships. FHA is independent from the employers of its founders.
Disclaimer
Nothing herein constitutes investment advice or a solicitation.
Contacts
info@femmehealthalliance.org
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:28:00 CEST | Press Release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press Release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 12:48:13 CEST | Press Release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom